An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

Name: An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
License: Public Domain

Dana-Farber Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

meningiomas

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623525
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.